@article{9ba1641430f04d7b96421dfd94e282ca,
title = "Left Ventricular Filling Pressures in Heart Failure With Preserved Ejection Fraction: Is the Tail Now Wagging the Dog?",
keywords = "diffusing capacity of carbon monoxide, filling pressures, heart failure with preserved ejection fraction, outcome, pulmonary hypertension",
author = "Masaru Obokata and Borlaug, {Barry A.}",
note = "Funding Information: Dr. Borlaug is supported by U.S. National Heart, Lung, and Blood Institute awards RO1 HL128526, R01 HL 126638, U01 HL125205, and U10 HL110262; has received research support from Mast Therapeutics, Medtronic, GlaxoSmithKline, Teva, and Novartis; and sits on the advisory boards of and consults for Actelion, Amgen, AstraZeneca, Merck, and Cardiokinetix. Dr. Obokata has reported he has no relationships relevant to the contents of this paper to disclose. ",
year = "2017",
month = nov,
doi = "10.1016/j.jchf.2017.09.001",
language = "English (US)",
volume = "5",
pages = "802--804",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "11",
}